Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial

Autor: Kersting, S., Levin, M-D., Chamuleau, M., Daenen, S. M. G. J., Dompeling, E. C., Doorduijn, J. K., van Gelder, M., Hoogendoorn, M., Kerst, J. M., Nijland, M., Nijziel, M. R., Posthuma, E. F. M., Raymakers, R. A. P., Schaafsma, M. R., Silbermann, M. H., van der Straaten, H. M., Veelken, J. H., Vos, J. M. I., Wittebol, S., van Oers, M. H. J., Kater, A. P.

Publikováno v: Netherlands Journal of Medicine, 74(2), 68-74. Van Zuiden Communications
Netherlands Journal of Medicine, 74(2), 68-74. Van Zuiden Communications BV
Kersting, S, Levin, M-D, Chamuleau, M, Daenen, S M G J, Dompeling, E C, Doorduijn, J K, van Gelder, M, Hoogendoorn, M, Kerst, J M, Nijland, M, Nijziel, M R, Posthuma, E F M, Raymakers, R A P, Schaafsma, M R, Silbermann, M H, van der Straaten, H M, Veelken, J H, Vos, J M I, Wittebol, S, van Oers, M H J & Kater, A P 2016, ' Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial ', Netherlands Journal of Medicine, vol. 74, no. 2, pp. 68-74 .

In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framew

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9d5c54eafc518eea04496b955628a9ed
https://cris.maastrichtuniversity.nl/en/publications/6322d8ef-c5c7-446b-a623-402090e2824e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative Group.

Autor: Ossenkoppele, G J, van der Holt, B, Verhoef, G E G, Daenen, S M G J, Verdonck, L F, Sonneveld, P, Wijermans, P W, van der Lelie, J, van Putten, W L J, Löwenberg, B, Verhoef, G E, Daenen, S M, van Putten, W L

Publikováno v: Leukemia (08876924); Aug99, Vol. 13 Issue 8, p1207-1213, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

R-DHAP Immuno-Chemotherapy Is An Effective Remission-Induction Treatment for Fludarabine Refractory CLL Patients and Allows the Majority to Proceed to Allogeneic Stem Cell Transplantation. Results of the Planned Interim Analysis of the Dutch-Belgian Prospective Multicenter HOVON88 Trial,

Autor: Van Gelder, Michel, Ghidey, Wendim ^*, Chamuleau, Martine ED, Cornelissen, Jan J, Wu, Ka Lung, Hoogendoorn, Mels ^*, Daenen, S. M. G.J., Petersen, Eefke, van Oers, Marinus H.J.

Publikováno v: In Blood 18 November 2011 118(21):3911-3911